FCMR and cancer: Based on our scRNAseq data, we hypothesized that increased expression of genes related to phagocytosis and antigen presentation/cross-presentation in Fcmr-deficient TMPs could explain the enhanced anti-cancer immunity in Fcmr−/− mice.